Awards Program

Dear colleagues,


The 1st Annual Meeting of the Brazil-Russia-India-China-South Africa IBD Consortium (BRICS IBD 2021) will provide a truly global perspective and an opportunity for clinicians and researchers from BRICS countries to present their research and interact with participants over the world. There will also be excellent opportunities for clinicians and researchers to get up-to-date information for inflammatory bowel disease.


Now, the 1st Annual Meeting of the BRICS IBD 2021 is gathering the abstracts for potential awards. This is your opportunity to network with other health professionals with similar interests in inflammatory bowel disease.


Get your award by submitting your latest results exploring new trends, discussing difficult issues, and getting expert guidance with ideas through a competitive evaluation by leaders of the BRICS IBD 2021. Here are some points worth your attention.

- Originality

- Clinical/scientific importance

- Reasonable experimental design and methods

- Scientific analysis of data (incl. statistics)

- Clarity of presentation

- The Best Abstract Award is given to the SIX top-ranking abstracts submitted to the 1st Annual Meeting of BRICS IBD, the corresponding author or the first authors of these SIX abstracts will be selected and receive $500 for his/her scientific merit of investigation. One of the authors will have the opportunity to give a 15-minite speech in the best abstract session.

- All applicants need to send their CVs to the secretariat in order to apply this award.

We sincerely hope that you will show your magnificent work to the BRICS IBD 2021. Get into the minds of how the leading IBD authorities think through different results and understand their decision-making process. If you think your abstract deserves special attention, like a presentation or/and editorial, do not hesitate to send your abstract to this meeting. We would like you to express your wonderful idea in the investigation of inflammatory bowel disease.

Copyright 漏 BRICS2021 All rights reserved.